Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort

Gustavo Ayala, Anna Frolov, Michael Ittman, Sayeed Mohammed, Mike LeBlanc, Seth Falcon, David Rowley, Ruth Etzioni

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: High-throughput analyses yielded a large number of predictive biomarkers in prostatic cancer (PCa) patients. Combinations of these biomarkers and with clinical features could improve on prediction. Materials and Methods: Tissue microarrays (640 patients) with triplicate cores of non-neoplastic prostate, benign prostatic hyperplasia (BPH), and index tumor were immunostained with antibodies to numerous biomarkers, digitized, and quantified. We used tree-based classification algorithms to stratify patients into 3 risk strata on the basis of their clinical and pathologic data. Markers were tested for prognostic ability in each stratum (stratum 1 had <10% risk of recurrence; stratum 3 had >60% likelihood of recurrence over a period >12 years). Sub stratification of the clinico-pathologic strata was also pursued. Results: We identified a number of significant predictors for PSA recurrence free survival, which were used to construct a predictive model that combines clinical and biomarker data. In the low-risk clinico-pathologic stratum, the markers were predominantly related to non-neoplastic tissues, in the moderate-risk stratum to stromal-epithelial interactions and angiogenesis, while those in the high-risk stratum were mostly oncogenes. Substratification of the intermediate risk group using stromal quantitation and proliferative index successfully, up or down, staged the risk strata for most patients. Conclusions: The fact that different biomarkers are most predictive of disease recurrence within different risk subgroups suggests an association between biological processes and prognostic ability. This is the first time that subgroup analysis of markers finds that prognostic ability is associated with biological processes and is proof of concept that distinct phenotypes are associated with risk of recurrence in different types of cancer.

Original languageEnglish (US)
Pages (from-to)11-21
Number of pages11
JournalAnnals of Clinical and Laboratory Science
Volume43
Issue number1
StatePublished - Mar 21 2013
Externally publishedYes

Fingerprint

Microarrays
Tissue
Biomarkers
Recurrence
Survival
Biological Phenomena
Prostatic Hyperplasia
Oncogenes
Tumors
Prostate
Neoplasms
Prostatic Neoplasms
Throughput
Association reactions
Phenotype
Antibodies

ASJC Scopus subject areas

  • Microbiology
  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology
  • Molecular Biology
  • Hematology
  • Clinical Biochemistry
  • Medical Laboratory Technology

Cite this

Ayala, G., Frolov, A., Ittman, M., Mohammed, S., LeBlanc, M., Falcon, S., ... Etzioni, R. (2013). Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort. Annals of Clinical and Laboratory Science, 43(1), 11-21.

Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort. / Ayala, Gustavo; Frolov, Anna; Ittman, Michael; Mohammed, Sayeed; LeBlanc, Mike; Falcon, Seth; Rowley, David; Etzioni, Ruth.

In: Annals of Clinical and Laboratory Science, Vol. 43, No. 1, 21.03.2013, p. 11-21.

Research output: Contribution to journalArticle

Ayala, G, Frolov, A, Ittman, M, Mohammed, S, LeBlanc, M, Falcon, S, Rowley, D & Etzioni, R 2013, 'Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort', Annals of Clinical and Laboratory Science, vol. 43, no. 1, pp. 11-21.
Ayala, Gustavo ; Frolov, Anna ; Ittman, Michael ; Mohammed, Sayeed ; LeBlanc, Mike ; Falcon, Seth ; Rowley, David ; Etzioni, Ruth. / Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort. In: Annals of Clinical and Laboratory Science. 2013 ; Vol. 43, No. 1. pp. 11-21.
@article{40a8cb18c042416abb6b63aea909aa58,
title = "Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort",
abstract = "Background: High-throughput analyses yielded a large number of predictive biomarkers in prostatic cancer (PCa) patients. Combinations of these biomarkers and with clinical features could improve on prediction. Materials and Methods: Tissue microarrays (640 patients) with triplicate cores of non-neoplastic prostate, benign prostatic hyperplasia (BPH), and index tumor were immunostained with antibodies to numerous biomarkers, digitized, and quantified. We used tree-based classification algorithms to stratify patients into 3 risk strata on the basis of their clinical and pathologic data. Markers were tested for prognostic ability in each stratum (stratum 1 had <10{\%} risk of recurrence; stratum 3 had >60{\%} likelihood of recurrence over a period >12 years). Sub stratification of the clinico-pathologic strata was also pursued. Results: We identified a number of significant predictors for PSA recurrence free survival, which were used to construct a predictive model that combines clinical and biomarker data. In the low-risk clinico-pathologic stratum, the markers were predominantly related to non-neoplastic tissues, in the moderate-risk stratum to stromal-epithelial interactions and angiogenesis, while those in the high-risk stratum were mostly oncogenes. Substratification of the intermediate risk group using stromal quantitation and proliferative index successfully, up or down, staged the risk strata for most patients. Conclusions: The fact that different biomarkers are most predictive of disease recurrence within different risk subgroups suggests an association between biological processes and prognostic ability. This is the first time that subgroup analysis of markers finds that prognostic ability is associated with biological processes and is proof of concept that distinct phenotypes are associated with risk of recurrence in different types of cancer.",
author = "Gustavo Ayala and Anna Frolov and Michael Ittman and Sayeed Mohammed and Mike LeBlanc and Seth Falcon and David Rowley and Ruth Etzioni",
year = "2013",
month = "3",
day = "21",
language = "English (US)",
volume = "43",
pages = "11--21",
journal = "Annals of Clinical and Laboratory Science",
issn = "0091-7370",
publisher = "Association of Clinical Scientists",
number = "1",

}

TY - JOUR

T1 - Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort

AU - Ayala, Gustavo

AU - Frolov, Anna

AU - Ittman, Michael

AU - Mohammed, Sayeed

AU - LeBlanc, Mike

AU - Falcon, Seth

AU - Rowley, David

AU - Etzioni, Ruth

PY - 2013/3/21

Y1 - 2013/3/21

N2 - Background: High-throughput analyses yielded a large number of predictive biomarkers in prostatic cancer (PCa) patients. Combinations of these biomarkers and with clinical features could improve on prediction. Materials and Methods: Tissue microarrays (640 patients) with triplicate cores of non-neoplastic prostate, benign prostatic hyperplasia (BPH), and index tumor were immunostained with antibodies to numerous biomarkers, digitized, and quantified. We used tree-based classification algorithms to stratify patients into 3 risk strata on the basis of their clinical and pathologic data. Markers were tested for prognostic ability in each stratum (stratum 1 had <10% risk of recurrence; stratum 3 had >60% likelihood of recurrence over a period >12 years). Sub stratification of the clinico-pathologic strata was also pursued. Results: We identified a number of significant predictors for PSA recurrence free survival, which were used to construct a predictive model that combines clinical and biomarker data. In the low-risk clinico-pathologic stratum, the markers were predominantly related to non-neoplastic tissues, in the moderate-risk stratum to stromal-epithelial interactions and angiogenesis, while those in the high-risk stratum were mostly oncogenes. Substratification of the intermediate risk group using stromal quantitation and proliferative index successfully, up or down, staged the risk strata for most patients. Conclusions: The fact that different biomarkers are most predictive of disease recurrence within different risk subgroups suggests an association between biological processes and prognostic ability. This is the first time that subgroup analysis of markers finds that prognostic ability is associated with biological processes and is proof of concept that distinct phenotypes are associated with risk of recurrence in different types of cancer.

AB - Background: High-throughput analyses yielded a large number of predictive biomarkers in prostatic cancer (PCa) patients. Combinations of these biomarkers and with clinical features could improve on prediction. Materials and Methods: Tissue microarrays (640 patients) with triplicate cores of non-neoplastic prostate, benign prostatic hyperplasia (BPH), and index tumor were immunostained with antibodies to numerous biomarkers, digitized, and quantified. We used tree-based classification algorithms to stratify patients into 3 risk strata on the basis of their clinical and pathologic data. Markers were tested for prognostic ability in each stratum (stratum 1 had <10% risk of recurrence; stratum 3 had >60% likelihood of recurrence over a period >12 years). Sub stratification of the clinico-pathologic strata was also pursued. Results: We identified a number of significant predictors for PSA recurrence free survival, which were used to construct a predictive model that combines clinical and biomarker data. In the low-risk clinico-pathologic stratum, the markers were predominantly related to non-neoplastic tissues, in the moderate-risk stratum to stromal-epithelial interactions and angiogenesis, while those in the high-risk stratum were mostly oncogenes. Substratification of the intermediate risk group using stromal quantitation and proliferative index successfully, up or down, staged the risk strata for most patients. Conclusions: The fact that different biomarkers are most predictive of disease recurrence within different risk subgroups suggests an association between biological processes and prognostic ability. This is the first time that subgroup analysis of markers finds that prognostic ability is associated with biological processes and is proof of concept that distinct phenotypes are associated with risk of recurrence in different types of cancer.

UR - http://www.scopus.com/inward/record.url?scp=84875075928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875075928&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 11

EP - 21

JO - Annals of Clinical and Laboratory Science

JF - Annals of Clinical and Laboratory Science

SN - 0091-7370

IS - 1

ER -